References
- J. W. Wiechers, The barrier functions of the skin in relation to percutaneous absorption of drugs, Pharm. Weekbl. 11 (1989) 185--198.
- D. C. Monkhouse and A. S. Huq, Transdermal drug delivery - problems and promises, Drug Dev. Ind. Pharm. 14 (1988) 183--203.
- M. B. Brown, G. P. Martin, S. A. Jones and F. K. Akomeah, Dermal and transdermal drug delivery systems: Current and future prospects, Drug Del. 13 (2006) 175--187; DOI: 10.1080/10717540500455975.
- B. T. Kurihara, W. R. Good, S. Feusullin and C. Signor, Skin compatibility of transdermal drug delivery system, J. Control. Rel. 15 (1991) 271--278; DOI: 10.1016/0168-3659(91)90119-X.
- T. Furuishi, S. Oda, H. Saito, T. Fukami, T. Suzuki and K. Tomono, Effect of permeation enhancers on the in vitro percutaneous absorption of pentazocine, Biol. Pharm. Bull. 30 (2007) 1350--1353.
- V. Agarwal and B. Mishra, Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine, Drug Dev. Ind. Pharm. 25 (1999) 701--709; DOI: 10.1081/DDC-100102229.
- M. Bhattacharyya, S. C. Mandal, B. Sa and B. K. Gupta, Studies on controlled release formulations of pentazocine hydrochloride, Drug Dev. Ind. Pharm. 20 (1994) 1613--1629; DOI: 10.3109/03639049409050202.
- C. Valenta and B. G. Auner, The use of polymers for dermal and transdermal delivery, Eur. J. Pharm. Biopharm. 58 (2004) 279--289; DOI: 10.1016/j.ejpb.2004.02.017.
- United States Pharmacopoeia 25, National Formulary 20, USP Convention, Rockville 2002, pp. 2018.
- P. R. P. Verma and S. S. Iyer, Transdermal delivery of propranolol using mixed grades of eudragit: design and in vitro and in vivo evaluation, Drug Dev. Ind. Pharm. 26 (2000) 471--476; DOI: 10.1081/DDC-100101257.
- A. R. Chandak and P. R. P. Verma, Development and evaluation of HPMC based matrices for transdermal patches of tramadol, Clin. Res. Reg. Affairs 25 (2008) 13--30; DOI: 10.1080/1060133-0701885066.
- M. Man, C. Chang, P. H. Lee, C. T. Broman and G. W. Cleary, New improved paddle method for determining the in vitro drug release profiles of transdermal delivery systems, Control. Rel. 27 (1993) 59--68; DOI: 10.1016/0168-3659(93)90057-C.
- B. Berkowitz and E. L. Way, Metabolism and excretion of pentazocine in man, Clin. Pharmacol. Ther. 10 (1969) 681--689.
- Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-mortem Materials, (Ed. A. C. Moffat), 2nd ed., Pharmaceutical Press, London 1986, pp. 860--861.
- S. Wartewig and R. H. H. Neubert, Pharmaceutical applications of Mid-IR and Raman spectroscopy, Adv. Drug Del. Rev. 57 (2005) 1144--1170; DOI: 10.1016/j.addr.2005.01.022.
- T. D. Wilson, Pentazocine, in Analytical Profiles of Drug Substance (Ed. K. Florey), Vol. 13, Pharmaceutical Press, London 1984, pp. 361--416.
- R. K. Verma and S. Garg, Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations, J. Pharm. Biomed. Anal. 35 (2004) 449--458; DOI:10.1016/j.jpba.2004.01.012.
- R. C. Mundargi, S. A. Patil, S. A. Agnihotri and T. M. Aminabhavi, Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol, Drug Dev. Ind. Pharm. 33 (2007) 79--90; DOI: 10.1080/03639040600975030.
- R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25--35; DOI: 10.1016/0378-5173(83) 90064-9.
- L. Perioli, V. Ambrogi, D. Rubini, S. Giovagnoli, M. Ricci, P. Blasi and C. Rossi, Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease, J. Control. Rel. 95 (2004) 521--533; DOI: 10.1016/j.jconrel.2003.12.018.
- S. Mutalik and N. Udupa, Glibenclamide transdermal patches: Physicochemical, pharmacodynamic, and pharmacokinetic evaluations, J. Pharm. Sci. 93 (2004) 1577--1594; DOI: 10.1002/jps. 20058.
- U. D. Rohr, R. Altenburger and T. Kissel, Pharmacokinetics of the transdermal reservoir membrane system delivering β-estradiol: in vitro/in vivo correlation, Pharm. Res. 15 (1998) 877--882.